XML 39 R21.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 13 - Revenue and Geographic Information
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

13. Revenue and Geographic Information

 

During the year ended December 31, 2024, the Company changed its classification of revenue. The Company previously disclosed revenue in 3 categories: OA Pain Management, Joint Preservation and Restoration and Non-Orthopedic. As a result of a change in strategic focus made in 2024, revenue classification was delineated to provide a clear view to the Company’s value drivers. Revenue will be split between the Commercial Channel and the Original Equipment Manufacturer (“OEM”) Channel. In the Commercial Channel, the Company has full responsibility for sales, marketing, and pricing of products through its commercial leaders, direct sales representatives, and independent distributors. Revenue from our Regenerative Solutions and international OA Pain Management businesses is included in the Commercial Channel. In the OEM Channel, the Company is responsible for development and manufacturing of products sold to the Company’s OEM partners governed by long-term agreements, but the Company does not control sales, marketing, or pricing with end users. Revenue from the Company’s U.S. OA Pain Management business and the Non-Orthopedic business is now included in the OEM Channel. All other revenue is reported in the Commercial Channel.

 

 

 

Product revenue by product family is as follows:

 

   

Years Ended December 31,

 
   

2024

   

2023

   

2022

 
   

Revenue

   

Percentage of
Product
Revenue

   

Revenue

   

Percentage of
Product
Revenue

   

Revenue

   

Percentage of
Product
Revenue

 

OEM Channel

  $ 77,770       65 %   $ 84,645       70 %   $ 81,675       72 %

Commercial Channel

    42,137       35 %     36,147       30 %     32,152       28 %

Total

  $ 119,907       100 %   $ 120,792       100 %   $ 113,827       100 %

 

Product revenue from the Company’s sole significant customer, J&J MedTech, as a percentage of the Company’s total product revenue was 57%, 62%, and 60% for the years ended December 31, 2024, 2023, and 2022, respectively.

 

Total revenue by geographic location based on the location of the customer in total and as a percentage of total revenue are as follows:

 

   

Years Ended December 31,

 
   

2024

   

2023

   

2022

 
   

Total

   

Percentage of

   

Total

   

Percentage of

   

Total

   

Percentage of

 
   

Revenue

   

Revenue

   

Revenue

   

Revenue

   

Revenue

   

Revenue

 

Geographic Location:

                                               

United States

  $ 82,446       69 %   $ 86,911       72 %   $ 83,746       74 %

Europe

    19,403       16 %     17,313       14 %     17,227       15 %

Other

    18,058       15 %     16,568       14 %     12,854       11 %

Total

  $ 119,907       100 %   $ 120,792       100 %   $ 113,827       100 %

 

Net long-lived assets, consisting primarily of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net tangible long-lived assets by principal geographic areas are as follows:

 

   

As of December 31,

 
   

2024

   

2023

 

United States

  $ 37,964     $ 36,324  

Italy

    1,001       1,075  

United Kingdom

    29       46  

Total

  $ 38,994     $ 37,445